While type 2 diabetes and obesity are the main conditions that GLP-1 agonists are used to treat, there is some evidence to suggest that they may also have additional health advantages aside from meaningful weight loss and metabolic health
Modern life with refined foods, over-the-counter painkillers, obesity, and sky-high stress levels robs our bodies of this vital antioxidant
Bakr RO, Amer RI, Attia D et al (2021) In-vivo wound healing activity of a novel composite sponge loaded with mucilage and lipoidal matter of Hibiscus species
1998 [cited 2025 Mar 16];26:21725
Additionally, hospitals tend to handle patients with comorbidities such as diabetes and cardiovascular conditions, where GLP-1 drugs provide dual benefits, further driving their use in this setting